Results 101 to 110 of about 469,149 (345)

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

E-Commerce Dispute Resolution Through Online Dispute Resolution

open access: yesSASI
Introduction: The rapid growth of the e-commerce industry has brought significant economic benefits. Still, it also raises challenges regarding dispute resolution that is efficient, fair and meets the needs of all parties. Purposes of the Research: This
Jusman Dg. Takenang   +4 more
doaj   +1 more source

Evaluating Dispute Resolution as an Approach to Public Participation [PDF]

open access: yes
Public participation has become an integral part of environmental policymaking. Dispute resolution—with its focus on deliberation, problem solving, and consensus seeking among a small group of people—is one of the alternatives decisionmakers increasingly
Beierle, Thomas, Cayford, Jerrell
core  

Empirical Perspectives on Mediation and Malpractice [PDF]

open access: yes, 1997
The use of mediation in the medical malpractice context is examined.
Metzloff, Thomas B.   +2 more
core   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

open access: yesMolecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh   +12 more
wiley   +1 more source

Medico-legal dispute resolution: Experience of a tertiary-care hospital in Singapore. [PDF]

open access: yesPLoS One, 2022
Lim LT   +6 more
europepmc   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy